Found 141 matching trials
A Korean Study of Efficacy and Safety of Aprepitant-based Triple Regimen for the Prevention of Chemotherapy-Induced Nausea and Vomiting in the First Cycle of Moderately Emetogenic Chemotherapy (Non-doxorubicin Hydrochloride [Adriamycin] and Cyclophosphamide Regimens) (MK-0869-225) (KMEC) PHASE4 This is an efficacy and safety study to compare aprepitant with ondansetron...
Show More Location
Multiple Locations
Learn More & Join Trial
Effect of Aprepitant on Cyclophosphamide Pharmacokinetics in Patients With Breast Cancer PHASE1 RATIONALE: Antiemetic drugs, such as aprepitant, may help lessen or prevent...
Show More Location
Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill
Learn More & Join Trial
A Study Evaluating the Efficacy and Safety of Bevacizumab in Combination With Chemotherapy in Untreated Metastatic Breast Cancer (RIBBON 1) PHASE3 This is a Phase III, multicenter, randomized, placebo-controlled trial desi...
Show More Location
Multiple Locations
Learn More & Join Trial
Neoadjuvant Chemotherapy With or Without Metformin in Early Breast Cancer. PHASE2 Metformin is a widely used anti-diabetic drug. Several studies have pointed...
Show More Location
Mansoura University Cancer center
Learn More & Join Trial
Tafasitamab + Lenalidomide + R-CHOP Versus R-CHOP in Newly Diagnosed High-intermediate and High Risk DLBCL Patients PHASE3 This is a phase 3, multicenter, randomized, double-blind, placebo-controlle...
Show More Status
Active Not Recruiting
Location
MorphoSys Research Site
Learn More & Join Trial
to Evaluate Efficacy and Safety of HLX10 in Combination With Chemotherapy Versus Placebo in Combination With Chemotherapy as Neoadjuvant Therapy and HLX10 Versus Placebo as Adjuvant Therapy in Patients With Triple Negative Breast Cancer (TNBC) PHASE3 This study is a randomized, double-Blind,international multi-Centre, phase ...
Show More Location
Multiple Locations
Learn More & Join Trial
Phase II Trial of Preoperative Therapy With Gefitinib and Chemotherapy in Patients With ERneg Breast Cancer PHASE2 The aim of the study is to estimate the effect of preoperative gefitinib on...
Show More Learn More & Join Trial
Evaluation of Possible Safety and Efficacy of Fenofibrate in the Prophylaxis of Doxorubicin Induced Cardiotoxicity in Breast Cancer Patients PHASE2 This study aims at evaluating the possible safety and efficacy of fenofibra...
Show More Learn More & Join Trial
Phase III Study of Tucidinostat in Combination With R-CHOP in Patients With Newly Diagnosed Double-Expressor DLBCL PHASE3 Tucidinostat (formerly known as chidamide) is an oral subtype-selective his...
Show More Location
Peking University Cancer Hospital
Learn More & Join Trial
A Study of Orelabrutinib Plus R-CHOP in Treatment-naïve Patients With MCD Subtype Diffuse Large B-cell Lymphoma PHASE3 The purpose of this study is to evaluate the safety and efficacy of orelabr...
Show More Location
The first affiliated hospital of bengbu medical college
Learn More & Join Trial